NCT01058408View on ClinicalTrials.gov

RAD001 With Weekly Cisplatin and Radiation Therapy in Patients With Locally Advanced Head and Neck Cancer

PHASE1TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

February 29, 2012

Conditions
Head and Neck Cancer
Interventions
RADIATION

Intensity modulated radiotherapy

Administered daily 5 days per week

DRUG

RAD001

Taken orally once a day

DRUG

cisplatin

Administered intravenously once a week

Trial Locations (1)

02115

Dana-Farber Cancer Institute, Boston

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

Novartis

INDUSTRY

lead

Dana-Farber Cancer Institute

OTHER